The GLP-1 consumer over-indexes on food and beverage at about 9% higher than the non-user. Circana data shows 5.3% of consumers are actively embracing GLP-1s, and the number may rise to double-digits for those who have at least tried the drug, according to Lyons Wyatt
With so many options, it can be confusing to know which one may be most suited to your needs
Trial data can help patients understand general medication trends, but a physician must interpret that information in the context of the individual patients health history, side-effect risk, current medications, and long-term goals
Precautions Use only under the supervision of a qualified healthcare professional
Walker is personally on Instagram or TikTok, and Walker jokes that maybe one day when Sarah stops making him spend all his time in the lab doing science, he'll start social media
Then he started taking semaglutide and following a lower-calorie diet